| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Animal models of chlamydia and atherosclerosis
|
Muhlestein, Joseph B.
|
|
1999
|
138 |
5S |
p. S514-S515
2 p.
|
artikel
|
| 2 |
Atherosclerosis induced by infection with Marek’s disease herpesvirus in chickens
|
Fabricant, Catherine G.
|
|
1999
|
138 |
5S |
p. S465-S468
4 p.
|
artikel
|
| 3 |
Atherosclerosis is an inflammatory disease
|
Ross, Russell
|
|
1999
|
138 |
5S |
p. S419-S420
2 p.
|
artikel
|
| 4 |
Autoimmunity and atherosclerosis
|
Wick, Georg
|
|
1999
|
138 |
5S |
p. S444-S449
6 p.
|
artikel
|
| 5 |
Chlamydia pneumoniae and atherosclerosis: Links to the disease process
|
Byrne, Gerald I.
|
|
1999
|
138 |
5S |
p. S488-S490
3 p.
|
artikel
|
| 6 |
Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease
|
Gupta, Sandeep
|
|
1999
|
138 |
5S |
p. S539-S541
3 p.
|
artikel
|
| 7 |
Conclusions
|
Plotkin, Stanley A.
|
|
1999
|
138 |
5S |
p. S560-
1 p.
|
artikel
|
| 8 |
Coronary artery disease after heart transplantation and its relation to cytomegalovirus
|
Hosenpud, Jeffrey D.
|
|
1999
|
138 |
5S |
p. S469-S472
4 p.
|
artikel
|
| 9 |
Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies
|
Danesh, John
|
|
1999
|
138 |
5S |
p. S434-S437
4 p.
|
artikel
|
| 10 |
Cytomegalovirus is involved in vascular pathology
|
Bruggeman, Cathrien
|
|
1999
|
138 |
5S |
p. S473-S475
3 p.
|
artikel
|
| 11 |
Cytomegalovirus vaccine
|
Plotkin, Stanley A.
|
|
1999
|
138 |
5S |
p. S484-S487
4 p.
|
artikel
|
| 12 |
Dental infections and atherosclerosis
|
Beck, James D.
|
|
1999
|
138 |
5S |
p. S528-S533
6 p.
|
artikel
|
| 13 |
Designing studies to confirm a link between viral infection and atherosclerosis
|
Hodinka, Richard L.
|
|
1999
|
138 |
5S |
p. S554-S555
2 p.
|
artikel
|
| 14 |
Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis
|
Grayston, J.Thomas
|
|
1999
|
138 |
5S |
p. S556-S557
2 p.
|
artikel
|
| 15 |
Diet and atherosclerosis
|
Kritchevsky, David
|
|
1999
|
138 |
5S |
p. S426-S430
5 p.
|
artikel
|
| 16 |
Emerging role of antibiotics in atherosclerosis
|
Gurfinkel, Enrique P.
|
|
1999
|
138 |
5S |
p. S537-S538
2 p.
|
artikel
|
| 17 |
Enteroviruses and myocardial infarction
|
Roivainen, Merja
|
|
1999
|
138 |
5S |
p. S479-S483
5 p.
|
artikel
|
| 18 |
Epidemiology of Chlamydia pneumoniae in atherosclerosis
|
Saikku, Pekka
|
|
1999
|
138 |
5S |
p. S500-S503
4 p.
|
artikel
|
| 19 |
Fulfillment of Koch’s postulates and the causes of atherosclerosis
|
O’Connor, Siobhán
|
|
1999
|
138 |
5S |
p. S550-S551
2 p.
|
artikel
|
| 20 |
Functionality of specific immunity in atherosclerosis
|
Nicoletti, Antonino
|
|
1999
|
138 |
5S |
p. S438-S443
6 p.
|
artikel
|
| 21 |
Helicobacter and atherosclerosis
|
Kusters, Johannes G.
|
|
1999
|
138 |
5S |
p. S523-S527
5 p.
|
artikel
|
| 22 |
How to design studies to confirm a link between bacterial infection and atherosclerosis
|
Campbell, Lee Ann
|
|
1999
|
138 |
5S |
p. S552-S553
2 p.
|
artikel
|
| 23 |
How to design vaccination trials to prevent atherosclerosis
|
Capron, Loïc
|
|
1999
|
138 |
5S |
p. S558-S559
2 p.
|
artikel
|
| 24 |
Infection and atherosclerosis
|
Dodet, Betty
|
|
1999
|
138 |
5S |
p. S417-S418
2 p.
|
artikel
|
| 25 |
Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis
|
Leinonen, Maija
|
|
1999
|
138 |
5S |
p. S504-S506
3 p.
|
artikel
|
| 26 |
In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells
|
Quinn, Thomas C.
|
|
1999
|
138 |
5S |
p. S507-S511
5 p.
|
artikel
|
| 27 |
Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity
|
Christiansen, Gunna
|
|
1999
|
138 |
5S |
p. S491-S495
5 p.
|
artikel
|
| 28 |
Molecular mediators of arterial inflammation: A role for microbial products?
|
Kol, Amir
|
|
1999
|
138 |
5S |
p. S450-S452
3 p.
|
artikel
|
| 29 |
Mouse models of Chlamydia pneumoniae infection and atherosclerosis
|
Campbell, Lee Ann
|
|
1999
|
138 |
5S |
p. S516-S518
3 p.
|
artikel
|
| 30 |
Multiple infections in carotid atherosclerotic plaques
|
Chiu, Brian
|
|
1999
|
138 |
5S |
p. S534-S536
3 p.
|
artikel
|
| 31 |
Pathologic manifestation of chlamydial infection
|
Kuo, Cho-chou
|
|
1999
|
138 |
5S |
p. S496-S499
4 p.
|
artikel
|
| 32 |
Potential role of cytomegalovirus in the pathogenesis of restenosis and atherosclerosis
|
Epstein, Stephen E.
|
|
1999
|
138 |
5S |
p. S476-S478
3 p.
|
artikel
|
| 33 |
Role of infections in atherosclerosis
|
Valtonen, Ville V.
|
|
1999
|
138 |
5S |
p. S431-S433
3 p.
|
artikel
|
| 34 |
Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: Design issues
|
Grayston, J.Thomas
|
|
1999
|
138 |
5S |
p. S545-S549
5 p.
|
artikel
|
| 35 |
Stable versus unstable atherosclerosis: Clinical aspects
|
Falk, Erling
|
|
1999
|
138 |
5S |
p. S421-S425
5 p.
|
artikel
|
| 36 |
Transgene as vaccine for chlamydia
|
Brunham, Robert Conrad
|
|
1999
|
138 |
5S |
p. S519-S522
4 p.
|
artikel
|
| 37 |
Value of animal models for Chlamydia pneumoniae -related atherosclerosis
|
Fong, I.W.
|
|
1999
|
138 |
5S |
p. S512-S513
2 p.
|
artikel
|
| 38 |
Viral activation of the coagulation cascade
|
Nicholson, Andrew C.
|
|
1999
|
138 |
5S |
p. S461-S464
4 p.
|
artikel
|
| 39 |
Viruses and atherosclerosis: A critical review of the epidemiologic evidence
|
Nieto, F.Javier
|
|
1999
|
138 |
5S |
p. S453-S460
8 p.
|
artikel
|
| 40 |
WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics
|
Dunne, Michael
|
|
1999
|
138 |
5S |
p. S542-S544
3 p.
|
artikel
|
Tijdschrift beschrijving